These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 19588966)

  • 21. Disubstituted 2-phenyl-benzopyranopyrimidine derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
    Wu WB; Chen SH; Hou JQ; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2011 Apr; 9(8):2975-86. PubMed ID: 21373680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monomorphic RNA G-quadruplex and polymorphic DNA G-quadruplex structures responding to cellular environmental factors.
    Zhang DH; Fujimoto T; Saxena S; Yu HQ; Miyoshi D; Sugimoto N
    Biochemistry; 2010 Jun; 49(21):4554-63. PubMed ID: 20420470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
    Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
    Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay.
    Jin Y; Li H; Bai J
    Anal Chem; 2009 Jul; 81(14):5709-15. PubMed ID: 19527045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
    Folini M; Pivetta C; Zagotto G; De Marco C; Palumbo M; Zaffaroni N; Sissi C
    Biochem Pharmacol; 2010 Jun; 79(12):1781-90. PubMed ID: 20206144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duplex dissociation of telomere DNAs induced by molecular crowding.
    Miyoshi D; Matsumura S; Nakano S; Sugimoto N
    J Am Chem Soc; 2004 Jan; 126(1):165-9. PubMed ID: 14709080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
    Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
    Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between human telomere and a carbazole derivative: a molecular dynamics simulation of a quadruplex stabilizer and telomerase inhibitor.
    Yang DY; Chang TC; Sheu SY
    J Phys Chem A; 2007 Sep; 111(38):9224-32. PubMed ID: 17630723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
    Tan JH; Ou TM; Hou JQ; Lu YJ; Huang SL; Luo HB; Wu JY; Huang ZS; Wong KY; Gu LQ
    J Med Chem; 2009 May; 52(9):2825-35. PubMed ID: 19354252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The recognition of higher-order G-quadruplex by chiral cyclic-helicene molecules.
    Xu Y; Yamazaki S; Osuga H; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):183-4. PubMed ID: 17150878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and stability of DNA quadruplexes under molecular crowding conditions.
    Karimata H; Miyoshi D; Sugimoto N
    Nucleic Acids Symp Ser (Oxf); 2005; (49):239-40. PubMed ID: 17150722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
    Gunaratnam M; Neidle S
    Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyrin derivatives for telomere binding and telomerase inhibition.
    Dixon IM; Lopez F; Estève JP; Tejera AM; Blasco MA; Pratviel G; Meunier B
    Chembiochem; 2005 Jan; 6(1):123-32. PubMed ID: 15551357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shedding light on the interaction between TMPyP4 and human telomeric quadruplexes.
    Martino L; Pagano B; Fotticchia I; Neidle S; Giancola C
    J Phys Chem B; 2009 Nov; 113(44):14779-86. PubMed ID: 19824637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G-quadruplexes as therapeutic targets.
    Neidle S; Read MA
    Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.